CIK 0001906324
- Large accelerated filer
QuidelOrtho Corp
Sign in to watch- Ticker
- QDEL
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Jan 1
- Entity type
- Operating
- EIN
- 874496285
- Phone
- +1 858-552-1100
- Business address
- 9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
- Former names
- Coronado Topco, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-31 | Hodges Michelle A. SVP, General Counsel | Grant or award | +1,020 | 11,763 | ||
| 2024-01-31 | Hodges Michelle A. SVP, General Counsel | Shares withheld for taxes | −340 | $68.51 | $23K | 11,423 |
| 2024-01-31 | Hodges Michelle A. SVP, General Counsel | Grant or award | +204 | 11,627 | ||
| 2024-01-31 | Hodges Michelle A. SVP, General Counsel | Shares withheld for taxes | −73 | $68.51 | $5K | 11,554 |
| 2024-01-31 | Hodges Michelle A. SVP, General Counsel | Exercise or conversion · Restricted Stock Units | −1,610 | 3,220 | ||
| 2024-01-31 | Hodges Michelle A. SVP, General Counsel | Exercise or conversion · Restricted Stock Units | −3,628 | 3,628 | ||
| 2024-01-31 | Hodges Michelle A. SVP, General Counsel | Exercise or conversion · Restricted Stock Units (Converted) | −1,020 | 0 | ||
| 2024-01-31 | Hodges Michelle A. SVP, General Counsel | Exercise or conversion · Restricted Stock Units (Premium ) | −204 | 0 | ||
| 2024-01-31 | Kroll Werner SVP, Research & Development | Grant or award | +3,628 | 33,343 | ||
| 2024-01-31 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −1,946 | $68.51 | $133K | 31,397 |
| 2024-01-31 | Kroll Werner SVP, Research & Development | Grant or award | +3,547 | 34,944 | ||
| 2024-01-31 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −1,806 | $68.51 | $124K | 33,138 |
| 2024-01-31 | Kroll Werner SVP, Research & Development | Exercise or conversion · Restricted Stock Units | −3,628 | 3,628 | ||
| 2024-01-31 | Kroll Werner SVP, Research & Development | Exercise or conversion · Restricted Stock Units | −3,547 | 3,548 | ||
| 2024-01-31 | Bujarski Robert Joseph EVP & COO | Grant or award | +3,219 | 39,685 | ||
| 2024-01-31 | Bujarski Robert Joseph EVP & COO | Shares withheld for taxes | −1,924 | $68.51 | $132K | 37,761 |
| 2024-01-31 | Bujarski Robert Joseph EVP & COO | Grant or award | +6,772 | 44,533 | ||
| 2024-01-31 | Bujarski Robert Joseph EVP & COO | Shares withheld for taxes | −3,857 | $68.51 | $264K | 40,676 |
| 2024-01-31 | Bujarski Robert Joseph EVP & COO | Exercise or conversion · Restricted Stock Units | −3,219 | 6,440 | ||
| 2024-01-31 | Bujarski Robert Joseph EVP & COO | Exercise or conversion · Restricted Stock Units | −6,772 | 6,773 |
Page 30 of 33 · 642 trades